{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:48:21Z","timestamp":1791856101276,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T00:00:00Z","timestamp":1462320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Estetra SPRL"},{"name":"Walloon Government","award":["C6139"],"award-info":[{"award-number":["C6139"]}]}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.contraception.2016.04.015","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T02:04:07Z","timestamp":1462327447000},"page":"366-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA)"],"prefix":"10.1016","volume":"94","author":[{"given":"Dan","family":"Apter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Beekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Mawet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Foidart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herjan J.T.","family":"Coelingh Bennink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2016.04.015_bb0005","doi-asserted-by":"crossref","first-page":"412.e1","DOI":"10.1016\/j.ajog.2006.12.015","article-title":"Oral contraceptive discontinuation: do side effects matter?","volume":"196","author":"Westhoff","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.04.015_bb0010","first-page":"299","article-title":"Pharmacological profile of estrogens in oral contraception","volume":"63","author":"Bitzer","year":"2011","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.contraception.2016.04.015_bb0015","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/GRF.0b013e318159c06a","article-title":"Combined oral contraceptives: a comprehensive review","volume":"50","author":"Kiley","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.04.015_bb0020","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2016.04.015_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-7824(99)00109-2","article-title":"Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations","volume":"60","author":"Rosenberg","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.04.015_bb0030","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0940-2993(98)80034-1","article-title":"Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives","volume":"50","author":"Hoffmann","year":"1998","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.contraception.2016.04.015_bb0035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/13625187.2011.614029","article-title":"Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17beta-oestradiol in a 24\/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21\/7 regimen","volume":"16","author":"Mansour","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2016.04.015_bb0040","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/AOG.0b013e318250c3a0","article-title":"Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17beta-estradiol: a randomized controlled trial","volume":"119","author":"Westhoff","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.04.015_bb0045","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.contraception.2009.03.018","article-title":"Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate\/dienogest and ethinyl estradiol\/levonorgestrel","volume":"80","author":"Ahrendt","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.04.015_bb0050","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.contraception.2011.11.011","article-title":"Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate\/dienogest","volume":"86","author":"Fraser","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.04.015_bb0055","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jsbmb.2008.03.027","article-title":"Estetrol: a unique steroid in human pregnancy","volume":"110","author":"Holinka","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2016.04.015_bb0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/13697130701851814","article-title":"Estetrol does not bind sex hormone binding globulin or increase its production by human HepG2 cells","volume":"11","author":"Hammond","year":"2008","journal-title":"Climacteric"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2016.04.015_bb0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/13697130802050340","article-title":"In vitro effects of estetrol on receptor binding, drug targets and human liver cell metabolism","volume":"11","author":"Visser","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2016.04.015_bb0070","series-title":"FDA label E2V\/DNG","year":"2012"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2016.04.015_bb0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/13697130802056511","article-title":"First human exposure to exogenous single-dose oral estetrol in early postmenopausal women","volume":"11","author":"Visser","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2016.04.015_bb0080","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.contraception.2007.11.014","article-title":"Ovulation inhibition by estetrol in an in vivo model","volume":"77","author":"Coelingh Bennink","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.04.015_bb0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jsbmb.2008.12.013","article-title":"Clinical applications for estetrol","volume":"114","author":"Visser","year":"2009","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2016.04.015_bb0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13697130802073425","article-title":"Estetrol review: profile and potential clinical applications","volume":"11","author":"Coelingh Bennink","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2016.04.015_bb0095","first-page":"476","article-title":"Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study","volume":"20","author":"Duijkers","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2016.04.015_bb0100","first-page":"463","article-title":"Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives","volume":"20","author":"Mawet","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2016.04.015_bb0105","series-title":"Medical eligibility criteria for contraceptive use","first-page":"15","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.contraception.2016.04.015_bb0110","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/13625187.2015.1048331","article-title":"Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation","volume":"20","author":"Roos","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2016.04.015_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2006.08.012","article-title":"Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials","volume":"75","author":"Mishell","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.04.015_bb0120","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/humrep\/deh604","article-title":"Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial","volume":"20","author":"Oddsson","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2016.04.015_bb0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00024677-200605020-00005","article-title":"A comparison of the cycle control, safety, and efficacy profile of a 21-day regimen of ethinylestradiol 20mug and drospirenone 3mg with a 21-day regimen of ethinylestradiol 20mug and desogestrel 150mug","volume":"5","author":"Gruber","year":"2006","journal-title":"Treat Endocrinol"},{"key":"10.1016\/j.contraception.2016.04.015_bb0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(99)00019-0","volume":"59","author":"DelConte","year":"1999","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416300506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416300506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T13:55:21Z","timestamp":1536760521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782416300506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0010782416300506"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2016.04.015","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA)","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2016.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}